The University of Manitoba campuses are located on original lands of Anishinaabeg, Cree, Oji-Cree, Dakota, and Dene peoples, and on the homeland of the Métis Nation. More
University of Manitoba
Winnipeg, Manitoba Canada, R3T 2N2
Max Rady College of Medicine
Biochemistry and Medical Genetics
Room 611 – Basic Medical Sciences Building
745 Bannatyne Avenue
University of Manitoba
Winnipeg, Manitoba R3E 0J9
Phone: 204-789-3431
tamra.ogilvie@umanitoba.ca
Twitter: @OgilvieTamra
Dr. Tamra Werbowetski-Ogilvie has made significant contributions to the underlying cellular and molecular mechanisms regulating stem cell function and heterogeneity in medulloblastoma (MB), the most common primary malignant childhood brain tumor.
Her lab has discovered central regulators of self-renewal (Nature Communications, 2020, Molecular Oncology, 2018, Disease Models & Mechanisms, 2015; Stem Cells, 2012) and potential diagnostic biomarkers for MB (Cancer Research, 2018).
Dr. Werbowetski-Ogilvie routinely utilizes model systems, some of which she first developed (Nature Biotechnology, 2009; Stem Cells, 2012), that most closely represent the human condition, including primary MB cells from patient tumors, MB-like cells derived from human neural precursor cells and mouse models where these cells are implanted into the cerebellum.
Over the last 10 years, Dr. Werbowetski-Ogilvie has been continuously supported by provincial, national and international funding agencies, including Research Manitoba, CHRIM, CancerCare Manitoba Foundation, the Canadian Institutes of Health Research (CIHR), NSERC, the Rally Foundation for Childhood Cancer Research (US) and Alex’s Lemonade Stand Foundation (US).
Dr. Tamra Werbowetski-Ogilvie received her honours bachelor of science in biology at the University Western Ontario in 2000. She completed her PhD in the department of neurology and neurosurgery, Montreal Neurological Institute at McGill University, with a research focus on malignant brain tumors in 2006.
Dr. Werbowetski-Ogilvie then pursued postdoctoral training in human stem cell biology at McMaster University, following which she joined the University of Manitoba as a principal investigator in the department of biochemistry and medical genetics and the regenerative medicine program in November, 2010.
Dr. Werbowetski-Ogilvie currently holds a Tier II Canada Research Chair in Neuro-Oncology and Human Stem Cells.
Visit Tamra Werbowetski-Ogilvie's ORCID profile for a complete listing, or find her on ResearchGate.
Biochemistry and Medical Genetics
Room 336 Basic Medical Sciences Building
745 Bannatyne Avenue
University of Manitoba
Winnipeg, MB R3E 0J9 Canada
